Clinical Trial Update: Evaluation of the Efficacy of Platelets Treated With Pathogen Reduction Process [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating efficacy of platelets treated with pathogen reduction process for aplasia with expected thrombocytopenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplasia with Expected Thrombocytopenia

Drugs mentioned

• Platelets treated with pathogen reduction process

Snippet

Sponsor: Etablissement Français du Sang | Conditions: Aplasia With Expected Thrombocytopenia | Phase 4 | Status: COMPLETED